Stay updated on Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.3 to v3.5.4, signaling a newer version of the study record page. This appears to be a metadata update rather than a substantive change to the trial details or eligibility criteria.
    Difference
    0.1%
    Check dated 2026-05-15T06:48:43.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    42 days ago
    Change Detected
    Summary
    The page revision identifier was incremented from v3.5.2 to v3.5.3, reflecting a site/version update rather than a change to the trial study details.
    Difference
    0.1%
    Check dated 2026-04-24T06:10:48.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:37:33.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was rolled out, replacing the previous v3.4.3 release. The update appears to be a routine site version upgrade with no visible changes to the study details or functionality on this page.
    Difference
    0.1%
    Check dated 2026-03-19T06:14:08.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    Version bumped from v3.4.2 to v3.4.3 on the site.
    Difference
    0.1%
    Check dated 2026-03-12T02:27:23.000Z thumbnail image
  9. Check
    113 days ago
    Change Detected
    Summary
    Revision: v3.4.2 replaces v3.4.1 in the page metadata. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-11T14:00:16.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs. Liver-Directed Therapy in NET Clinical Trial page.